Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML - HSA Drug Approval Details

Approvals/HSA/XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML

Approved

THERAPEUTIC

XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML

Aspiro Pharma Limited🇸🇬 Health Sciences Authority

Approval Date: Jun 12, 2020
Approval ID: bccfa097f09571cd
Company: Aspiro Pharma Limited
Type: Therapeutic

Approval Details

Approval Id: bccfa097f09571cd
Drug Name: XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML
Product Name: XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML
Approval Number: SIN15953P
Approval Date: 2020-06-12
Registrant: HETERO SINGAPORE PTE. LTD.
Licence Holder: HETERO SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION, SOLUTION
Route Of Administration: INTRAVENOUS
Atc Code: N01BB02
Atc Item Name: lidocaine
Pharma Manufacturer Name: HETERO SINGAPORE PTE. LTD.
Company Detail Path: /organization/923002e427d763bc/hetero-singapore-pte-ltd

Active Ingredients

Lidocaine Hydrochloride

300mg/30ml

LIDOCAINE HYDROCHLORIDE

300 MG/30 ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jun 12, 2020

Approval ID

bccfa097f09571cd

Type

Therapeutic

Back to HSA Approvals